Overview

Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to see if stress doses of hydrocortisone improve early outcome in patients who are in early stage of ARDS and with relative adrenal insufficiency.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Southeast University, China
Collaborator:
Nanjing Medical University
Treatments:
Cortisol succinate
Glucocorticoids
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Criteria
Inclusion Criteria:

- within the first 3 days of onset of clinically definite ARDS confirmed by AECC
criteria in 1994

- 18 to 85 year old

Exclusion Criteria:

- pregnancy or lactation

- tumor or other immunologic disease

- immunosuppressive drug used

- bone marrow or lung transplantation

- primary or secondary disease of adrenal gland

- hormone used within 3 months

- refusing conventional therapy

- be in other clinical tests within 30 days